Intellia Therapeutics, Inc. - COM (NTLA)

Historical Portfolio Holders from Q2 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
87.1 M
Holdings value Q1 2024
$2.4 B
Value change Q1 2024
+$144 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
266
Number of buys Q1 2024
142
Number of sells Q1 2024
-124
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
45826J105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 87.1 M $2.4 B +$144 M $27.51 266
2023 Q4 82.5 M $2.51 B +$151 M $30.49 284
2023 Q3 78.7 M $2.49 B +$57.8 M $31.62 272
2023 Q2 76.4 M $3.12 B -$39.8 M $40.78 278
2023 Q1 78.1 M $2.9 B +$28.2 M $37.27 280
2022 Q4 77.4 M $2.7 B +$329 M $34.89 285
2022 Q3 67.6 M $3.78 B -$10.1 M $55.96 300
2022 Q2 67.4 M $3.43 B +$102 M $51.76 278
2022 Q1 64.6 M $4.68 B -$33.8 M $72.67 334
2021 Q4 63.8 M $7.55 B +$200 M $118.24 356
2021 Q3 61.8 M $8.29 B +$33.8 M $134.15 352
2021 Q2 61.9 M $10 B +$30 M $161.91 335
2021 Q1 62.8 M $5.04 B +$267 M $80.25 255
2020 Q4 61.4 M $3.34 B +$177 M $54.40 234
2020 Q3 56.3 M $1.12 B +$49.2 M $19.88 156
2020 Q2 53.9 M $1.13 B +$161 M $21.02 156
2020 Q1 46.4 M $568 M +$9.03 M $12.23 129
2019 Q4 45.6 M $669 M +$24.4 M $14.67 133
2019 Q3 44.1 M $589 M +$69.2 M $13.35 129
2019 Q2 38.7 M $634 M +$80.4 M $16.37 139
2019 Q1 33.5 M $570 M +$44.7 M $17.08 141
2018 Q4 31.5 M $430 M +$12.3 M $13.65 133
2018 Q3 29.1 M $833 M +$9.98 M $28.62 149
2018 Q2 28.7 M $786 M +$69.1 M $27.36 150
2018 Q1 26.3 M $554 M +$48.1 M $21.09 126
2017 Q4 24.2 M $464 M +$126 M $19.22 105
2017 Q3 17.7 M $439 M +$20.6 M $24.85 83
2017 Q2 16.8 M $269 M +$2.72 M $16.00 80
2017 Q1 16.5 M $233 M -$10.2 M $14.09 73
2016 Q4 18.1 M $238 M -$5.66 M $13.11 64
2016 Q3 14.3 M $243 M +$998 K $17.02 64
2016 Q2 14.1 M $300 M +$298 M $21.35 61